The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 300.00
Ask: 304.00
Change: 0.00 (0.00%)
Spread: 4.00 (1.333%)
Open: 296.00
High: 304.00
Low: 296.00
Prev. Close: 300.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half year trading update

17 Jul 2023 07:00

RNS Number : 1487G
Fisher (James) & Sons plc
17 July 2023
 

17 July 2023

James Fisher and Sons plc

Half year trading update

 

James Fisher and Sons plc (FSJ.L) ("James Fisher" or the "Group"), today provides an update on trading for the six months ended 30 June 2023 ("the period"), ahead of the publication of its Half Year results on 21 September 2023.

 

Trading summary

The Board is pleased to report that the encouraging start to the year was maintained through the second quarter. Group revenue from continuing operations in the period is expected to be c.£250m, representing growth of c.16% compared to the same period in 2022. Underlying operating profit and operating profit margin from continuing operations are both expected to show modest growth compared to the same period in 2022, with the revenue uplift more than offsetting increased investment to strengthen core capabilities within the Group, including the formation of our Business Excellence team. 

 

All three divisions delivered revenue and profit growth compared to the same period in 2022, with the Energy division performing particularly well following strong market demand for well-testing, bubble curtain and artificial lift products and services. Defence is expected to report a modest profit for the period compared to a modest loss in 2022. Within the Maritime Transport division, Tankships has maintained its good performance, with high tanker utilisation and solid day rates for spot charters. Fendercare's ship-to-ship transfer business has stabilised at levels in line with H2 2022.

 

Financial position

Net bank borrowings at 30 June 2023 were c.£147m, compared to £133m at 31 December 2022. The normal seasonality of the business, unwind of working capital balances and costs associated with the £210m new revolving credit facility have led to a cash outflow in the first half of the year despite asset sales generating net proceeds of c.£20m in the period. The Group continues to expect net bank borrowings to reduce by the end of the 2023 financial year, in line with its usual trading profile.

 

Outlook

The Group enters the second half of the year mindful of heightened macro-economic uncertainty, however the Group's markets remain resilient and the Board's expectations for the full year remain unchanged.

 

Jean Vernet, Chief Executive Officer, commented:

"I am pleased with the Group's first half performance, with all three divisions contributing to revenue growth of 16%, alongside a modest improvement in margins. We are starting to see the benefits of the operational improvements being implemented throughout James Fisher. These, combined with the previously announced business and asset disposals and the refinancing concluded in June, provide us with a stronger platform for the future. Despite uncertainty in the macro-economic environment, the Group's markets remain resilient and the Board's outlook for the full year remains unchanged."

 

For further information:

James Fisher and Sons plc

Jean Vernet

Duncan Kennedy

Chief Executive Officer

Chief Financial Officer

020 7614 9503

FTI Consulting

Richard Mountain

Susanne Yule

0203 727 1340

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUQWMUPWPUQ
Date   Source Headline
22nd Mar 20224:35 pmRNSHolding(s) in Company
10th Mar 20227:00 amRNSFull year results for the year ended 31 Dec 21
24th Jan 202210:54 amRNSDirector Declaration
29th Dec 20219:55 amRNSMozambique update
17th Dec 20217:00 amRNSAppointment of non-executive director
15th Dec 20215:36 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:22 pmRNSHolding(s) in Company
18th Nov 202110:25 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSSale of James Fisher Testing Services for £5.7m
1st Nov 20215:23 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSTrading update
22nd Oct 20218:00 amRNSAppointment of non-executive director
15th Sep 20211:26 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf year results for the 6 months ended 30 Jun 21
1st Jul 20217:00 amRNSSale of Paladin for US$17.3m
29th Jun 20217:00 amRNSCapital Markets Event & Pre Close Trading Update
15th Jun 20213:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jun 20214:16 pmRNSDirector/PDMR Shareholding
30th Apr 202111:59 amRNSDirector Declaration
29th Apr 20212:01 pmRNSResult of Annual General Meeting
29th Apr 20217:00 amRNSAGM Trading Statement
20th Apr 20217:00 amRNSAppointment of Chief Financial Officer
13th Apr 202111:32 amRNSWithdrawal of Annual General Meeting Resolution
9th Apr 202110:18 amRNSDirector/PDMR Shareholding
8th Apr 20213:58 pmRNSDirector/PDMR Shareholding
6th Apr 20213:48 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights and Share Capital
29th Mar 20217:00 amRNSDirectorate Change
23rd Mar 202112:58 pmRNSAnnual Report and Notice of AGM posted
19th Mar 20211:17 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSResults for the year ended 31 December 2020
25th Feb 202110:42 amRNSNotification of FY Results Date
25th Jan 20217:00 amRNSAngus Cockburn appointed as Chairman
7th Jan 20217:00 amRNSPost close trading update
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 202011:18 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Nov 20207:00 amRNSDirector/PDMR Shareholding
9th Nov 20205:25 pmRNSTotal Voting Rights
6th Nov 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSTotal Voting Rights
23rd Oct 20209:48 amRNSDirector/PDMR Shareholding
6th Oct 20203:58 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSRoyal Navy contract award
21st Sep 20204:00 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSHalf-year results
24th Jul 202012:00 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHalf year post close trading update
24th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.